Novartis in drug patent fight

Rally in New Delhi condemns legal challenge by leukaemia drug manufacturer.

    Several Indian drug companies already make generic copies of Gleevec at a tenth of Novartis's price

    Essential medicines
     
    Non-governmental organisations fear a victory for Novartis could set a precedent for other pharmaceutical companies seeking patent protection for essential medicines.
     
    These would include antiretroviral Aids drugs, currently made cheaply in places like India. India's patent law, which came into effect on January 1, 2005, allows patents for products that represent new inventions after 1995, the year India joined the World Trade Organisation, or for an updated drug that shows greater efficacy.
     
    Novartis insists that its improved drug is more easily absorbed by the body.
     
    But Indian drug companies and aid groups say Gleevec is a new form of an old drug invented before 1995.
     
    Several Indian pharmaceutical companies already make generic copies of Gleevec, but sell it at a tenth of the $2,600 price for a monthly dose charged by the Swiss company.
     
    Criticism
     
    Unni Karunakara of Medecins San Frontieres, the international aid group, said: "Novartis is trying to shut down the pharmacy of the developing world."
     
    The group, along with Oxfam, has submitted a 250,000-signature petition to Novartis asking it to drop its case.
     
    Novartis has defended its position and said it will offer its leukaemia drug for free to patients who cannot afford it even if it wins the case.
     
    Paul Herrling, head of Novartis's corporate research, said: "We don't fight for Gleevec, we fight for the principle."
     
    Indian companies make a host of other generic drugs, available at a fraction of the price of branded medicine and used throughout the developing world.

    SOURCE: Agencies


    YOU MIGHT ALSO LIKE

    The Muslims of South Korea

    The Muslims of South Korea

    The number of Muslims in South Korea is estimated to be around 100,000, including foreigners.

    Gender violence in India: 'Daughters are not a burden'

    Gender violence in India: 'Daughters are not a burden'

    With female foeticide still widespread, one woman tells her story of being mutilated for giving birth to her daughters.

    Zimbabwe: What's happening?

    Zimbabwe: What's happening?

    Situation tense as thousands march in Harare to call for Robert Mugabe's resignation days after military takeover.